Armstrong SA - Search Results

1

IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation.

Park SM, Cho H, Thornton AM, Barlowe TS, Chou T, Chhangawala S, Fairchild L, Taggart J, Chow A, Schurer A, Gruet A, Witkin MD, Kim JH, Shevach EM, Krivtsov A, Armstrong SA, Leslie C, Kharas MG. Park SM, et al. Among authors: armstrong sa. Cell Stem Cell. 2019 Jan 3;24(1):153-165.e7. doi: 10.1016/j.stem.2018.10.016. Epub 2018 Nov 21. Cell Stem Cell. 2019. PMID: 30472158 Free PMC article.

2

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ. Armstrong SA, et al. Cancer Cell. 2003 Feb;3(2):173-83. doi: 10.1016/s1535-6108(03)00003-5. Cancer Cell. 2003. PMID: 12620411 Free article.

3

Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.

Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ. Wang J, et al. Among authors: armstrong sa. EMBO J. 2005 Jan 26;24(2):368-81. doi: 10.1038/sj.emboj.7600521. Epub 2005 Jan 6. EMBO J. 2005. PMID: 15635450 Free PMC article.

4

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, Golub TR, Armstrong SA. Krivtsov AV, et al. Among authors: armstrong sa. Nature. 2006 Aug 17;442(7104):818-22. doi: 10.1038/nature04980. Epub 2006 Jul 16. Nature. 2006. PMID: 16862118

5

FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.

Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C, Armstrong SA, Passegué E, DePinho RA, Gilliland DG. Tothova Z, et al. Among authors: armstrong sa. Cell. 2007 Jan 26;128(2):325-39. doi: 10.1016/j.cell.2007.01.003. Cell. 2007. PMID: 17254970 Free article.

6

Therapeutic implications of leukemia stem cell development.

Stubbs MC, Armstrong SA. Stubbs MC, et al. Among authors: armstrong sa. Clin Cancer Res. 2007 Jun 15;13(12):3439-42. doi: 10.1158/1078-0432.CCR-06-3090. Clin Cancer Res. 2007. PMID: 17575205 Review.

7

MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.

Stubbs MC, Kim YM, Krivtsov AV, Wright RD, Feng Z, Agarwal J, Kung AL, Armstrong SA. Stubbs MC, et al. Among authors: armstrong sa. Leukemia. 2008 Jan;22(1):66-77. doi: 10.1038/sj.leu.2404951. Epub 2007 Sep 13. Leukemia. 2008. PMID: 17851551 Free PMC article.

8

Mixed lineage leukemia translocations and a leukemia stem cell program.

Faber J, Armstrong SA. Faber J, et al. Among authors: armstrong sa. Cancer Res. 2007 Sep 15;67(18):8425-8. doi: 10.1158/0008-5472.CAN-07-0972. Cancer Res. 2007. PMID: 17875678 Review.

9

MLL translocations, histone modifications and leukaemia stem-cell development.

Krivtsov AV, Armstrong SA. Krivtsov AV, et al. Among authors: armstrong sa. Nat Rev Cancer. 2007 Nov;7(11):823-33. doi: 10.1038/nrc2253. Nat Rev Cancer. 2007. PMID: 17957188 Review.

10

Defining leukemia stem cells in MLL-translocated leukemias: implications for novel therapeutic strategies.

Faber J, Armstrong SA. Faber J, et al. Among authors: armstrong sa. Klin Padiatr. 2007 Nov-Dec;219(6):306-11. doi: 10.1055/s-2007-985878. Klin Padiatr. 2007. PMID: 18050039 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page